Literature DB >> 15899480

Inhibition by agmatine on morphine-induced conditioned place preference in rats.

Xiao-Li Wei1, Rui-Bin Su, Xin-Qiang Lu, Yin Liu, Shou-Zhong Yu, Ben-Li Yuan, Jin Li.   

Abstract

Our previous studies demonstrated the ability of exogenous agmatine to inhibit tolerance to and physical dependence on morphine in mice, rats and monkeys. The present study further evaluated the effect of agmatine on the psychological dependence induced by morphine in conditioned place preference assay. Agmatine (0.75-20 mg/kg, s.c.) co-administered with morphine during the conditioning sessions completely abolished the acquisition of morphine-induced conditioned place preference in rats, which was associated with activation of imidazoline receptors. Agmatine (0.75-10 mg/kg, s.c.) administered on the test day inhibited the expression of the place preference. After 30 days of extinction of conditioned place preference, agmatine 2.5 and 40 mg/kg inhibited the priming effect of morphine 0.5 mg/kg on the place preference. Furthermore, agmatine inhibited the increased expression of FosB in the nucleus accumbens caused by chronic morphine. All these results suggest that agmatine could inhibit morphine-induced psychological dependence and relapses by affecting the expression of transcription factor FosB.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15899480     DOI: 10.1016/j.ejphar.2005.03.045

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

Review 1.  Recent progress in the research field of neuropharmacology in China.

Authors:  Jin Li
Journal:  Cell Mol Neurobiol       Date:  2008-02-01       Impact factor: 5.046

2.  Agmatine Prevents Adaptation of the Hippocampal Glutamate System in Chronic Morphine-Treated Rats.

Authors:  Xiao-Fei Wang; Tai-Yun Zhao; Rui-Bin Su; Ning Wu; Jin Li
Journal:  Neurosci Bull       Date:  2016-05-09       Impact factor: 5.203

Review 3.  Agmatine : metabolic pathway and spectrum of activity in brain.

Authors:  Angelos Halaris; John Plietz
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 4.  Agmatine and imidazoline receptors: their role in opioid analgesia, tolerance and dependence.

Authors:  Ning Wu; Rui-Bin Su; Jin Li
Journal:  Cell Mol Neurobiol       Date:  2007-07-25       Impact factor: 5.046

5.  A Nonrewarding NMDA Receptor Antagonist Impairs the Acquisition, Consolidation, and Expression of Morphine Conditioned Place Preference in Mice.

Authors:  Lediane Tomazi; Carlos Fernando Mello; Ana Paula Schöffer; Bruna Amanda Girardi; Pâmella Karina Santana Frühauf; Maribel Antonello Rubin
Journal:  Mol Neurobiol       Date:  2016-01-14       Impact factor: 5.590

6.  Inhibition of phosphodiesterase10A attenuates morphine-induced conditioned place preference.

Authors:  Ying Mu; Zhaoxiang Ren; Jia Jia; Bo Gao; Longtai Zheng; Guanghui Wang; Eitan Friedman; Xuechu Zhen
Journal:  Mol Brain       Date:  2014-09-25       Impact factor: 4.041

7.  A Conantokin Peptide Con-T[M8Q] Inhibits Morphine Dependence with High Potency and Low Side Effects.

Authors:  Zhuguo Liu; Zheng Yu; Shuo Yu; Cui Zhu; Mingxin Dong; Wenxiang Mao; Jie Hu; Mary Prorok; Ruibin Su; Qiuyun Dai
Journal:  Mar Drugs       Date:  2021-01-19       Impact factor: 5.118

8.  Effects of imidazoline agents in a rat conditioned place preference model of addiction.

Authors:  V Şorodoc; G Rusu-Zota; P Nechita; C Moraru; O M Manole
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-01-08       Impact factor: 3.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.